Protherics PLC Announces Interest In Shares

London, UK; Brentwood, TN, US; 17 January 2007 - Protherics PLC ("Protherics" or the "Company"), the international biopharmaceutical company focused on critical care and cancer, today announces that, on 16 January 2007, notification was received from Artemis Investment Management Limited that, following the increase in the share capital of Protherics which took place on 4 January 2007, Artemis Income as beneficial owners of the shares within Artemis Investment Management Ltd, no longer have a notifiable interest in the shares of Protherics.
MORE ON THIS TOPIC